250 related articles for article (PubMed ID: 10482146)
1. Comparison of cilostazol versus ticlopidine therapy after stent implantation.
Park SW; Lee CW; Kim HS; Lee HJ; Park HK; Hong MK; Kim JJ; Park SJ
Am J Cardiol; 1999 Sep; 84(5):511-4. PubMed ID: 10482146
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of cilostazol versus ticlopidine in coronary artery stenting.
Yoon Y; Shim WH; Lee DH; Pyun WB; Kim IJ; Jang Y; Cho SY
Am J Cardiol; 1999 Dec; 84(12):1375-80. PubMed ID: 10606107
[TBL] [Abstract][Full Text] [Related]
3. Effects of cilostazol on angiographic restenosis after coronary stent placement.
Park SW; Lee CW; Kim HS; Lee NH; Nah DY; Hong MK; Kim JJ; Park SJ
Am J Cardiol; 2000 Sep; 86(5):499-503. PubMed ID: 11009265
[TBL] [Abstract][Full Text] [Related]
4. RACTS: a prospective randomized antiplatelet trial of cilostazol versus ticlopidine in patients undergoing coronary stenting: long-term clinical and angiographic outcome.
Ge J; Han Y; Jiang H; Sun B; Chen J; Zhang S; Du Z;
J Cardiovasc Pharmacol; 2005 Aug; 46(2):162-6. PubMed ID: 16044027
[TBL] [Abstract][Full Text] [Related]
5. Effect of cilostazol on restenosis after coronary angioplasty and stenting in comparison to conventional coronary artery stenting with ticlopidine.
Tanabe Y; Ito E; Nakagawa I; Suzuki K
Int J Cardiol; 2001 May; 78(3):285-91. PubMed ID: 11376832
[TBL] [Abstract][Full Text] [Related]
6. Randomized comparison of cilostazol versus ticlopidine hydrochloride for antiplatelet therapy after coronary stent implantation for prevention of late restenosis.
Kamishirado H; Inoue T; Mizoguchi K; Uchida T; Nakata T; Sakuma M; Takayanagi K; Morooka S
Am Heart J; 2002 Aug; 144(2):303-8. PubMed ID: 12177649
[TBL] [Abstract][Full Text] [Related]
7. Triple versus dual antiplatelet therapy after coronary stenting: impact on stent thrombosis.
Lee SW; Park SW; Hong MK; Kim YH; Lee BK; Song JM; Han KH; Lee CW; Kang DH; Song JK; Kim JJ; Park SJ
J Am Coll Cardiol; 2005 Nov; 46(10):1833-7. PubMed ID: 16286167
[TBL] [Abstract][Full Text] [Related]
8. [Effects of cilostazol on long-term clinical outcomes after coronary stenting].
Han YL; Wang SL; Li Y; Jing QM; Ma YY; Deng J; Yang GT; Yu HB; Ge JB
Zhonghua Nei Ke Za Zhi; 2005 Nov; 44(11):814-7. PubMed ID: 16316558
[TBL] [Abstract][Full Text] [Related]
9. [The effects of post coronary stenting triple antiplatelet therapies on platelet functions].
Han YL; Su QF; Li Y; Kang J; Yan CH; Wang SL
Zhonghua Nei Ke Za Zhi; 2006 Aug; 45(8):635-8. PubMed ID: 17074146
[TBL] [Abstract][Full Text] [Related]
10. Adjunctive cilostazol versus double-dose clopidogrel after drug-eluting stent implantation: the HOST-ASSURE randomized trial (Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis-Safety & Effectiveness of Drug-Eluting Stents & Anti-platelet Regimen).
Park KW; Kang SH; Park JJ; Yang HM; Kang HJ; Koo BK; Park BE; Cha KS; Rhew JY; Jeon HK; Shin ES; Oh JH; Jeong MH; Kim S; Hwang KK; Yoon JH; Lee SY; Park TH; Moon KW; Kwon HM; Chae IH; Kim HS
JACC Cardiovasc Interv; 2013 Sep; 6(9):932-42. PubMed ID: 24050860
[TBL] [Abstract][Full Text] [Related]
11. Triple antiplatelet therapy reduces ischemic events after drug-eluting stent implantation: Drug-Eluting stenting followed by Cilostazol treatment REduces Adverse Serious cardiac Events (DECREASE registry).
Lee SW; Park SW; Yun SC; Kim YH; Park DW; Kim WJ; Lee JY; Lee CW; Hong MK; Kim JJ; Park SJ
Am Heart J; 2010 Feb; 159(2):284-291.e1. PubMed ID: 20152228
[TBL] [Abstract][Full Text] [Related]
12. Multicenter randomized trial evaluating the efficacy of cilostazol on ischemic vascular complications after drug-eluting stent implantation for coronary heart disease: results of the CILON-T (influence of CILostazol-based triple antiplatelet therapy ON ischemic complication after drug-eluting stenT implantation) trial.
Suh JW; Lee SP; Park KW; Lee HY; Kang HJ; Koo BK; Cho YS; Youn TJ; Chae IH; Choi DJ; Rha SW; Bae JH; Kwon TG; Bae JW; Cho MC; Kim HS
J Am Coll Cardiol; 2011 Jan; 57(3):280-9. PubMed ID: 21232664
[TBL] [Abstract][Full Text] [Related]
13. Comparison of cilostazol and ticlopidine for one-month effectiveness and safety after elective coronary stenting.
Hashiguchi M; Ohno K; Nakazawa R; Kishino S; Mochizuki M; Shiga T
Cardiovasc Drugs Ther; 2004 May; 18(3):211-7. PubMed ID: 15229389
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of clopidogrel and aspirin versus ticlopidine and aspirin in preventing stent thrombosis after coronary stent implantation.
Moussa I; Oetgen M; Roubin G; Colombo A; Wang X; Iyer S; Maida R; Collins M; Kreps E; Moses JW
Circulation; 1999 May; 99(18):2364-6. PubMed ID: 10318654
[TBL] [Abstract][Full Text] [Related]
15. A randomized, double-blind, multicenter comparison study of triple antiplatelet therapy with dual antiplatelet therapy to reduce restenosis after drug-eluting stent implantation in long coronary lesions: results from the DECLARE-LONG II (Drug-Eluting Stenting Followed by Cilostazol Treatment Reduces Late Restenosis in Patients with Long Coronary Lesions) trial.
Lee SW; Park SW; Kim YH; Yun SC; Park DW; Lee CW; Kang SJ; Park SJ; Lee JH; Choi SW; Seong IW; Lee NH; Cho YH; Shin WY; Lee SJ; Lee SW; Hyon MS; Bang DW; Choi YJ; Kim HS; Lee BK; Lee K; Park HK; Park CB; Lee SG; Kim MK; Park KH; Park WJ;
J Am Coll Cardiol; 2011 Mar; 57(11):1264-70. PubMed ID: 21392640
[TBL] [Abstract][Full Text] [Related]
16. Detection of clopidogrel hyporesponsiveness using a point-of-care assay and the impact of additional cilostazol administration after coronary stent implantation in diabetic patients.
Yang TH; Kim DI; Kim DK; Jang JS; Kim U; Seol SH; Kim DK; Hong GR; Park JS; Shin DG; Kim YJ; Cho YK; Nam CW; Hur SH; Kim KB; Kim DS
Korean J Intern Med; 2011 Jun; 26(2):145-52. PubMed ID: 21716590
[TBL] [Abstract][Full Text] [Related]
17. Randomized Angiographic and Intravascular Ultrasound Comparison of Dual-Antiplatelet Therapy vs Triple-Antiplatelet Therapy to Reduce Neointimal Tissue Proliferation in Diabetic Patients.
Zuliani Mauro MF; Mangione JA; Costa JR; Costa R; Piva E Mattos LA; Staico R; Feres F; Siqueira D; Sousa A; Abizaid A
J Invasive Cardiol; 2017 Mar; 29(3):76-81. PubMed ID: 28255102
[TBL] [Abstract][Full Text] [Related]
18. Drug-eluting stenting followed by cilostazol treatment reduces late restenosis in patients with diabetes mellitus the DECLARE-DIABETES Trial (A Randomized Comparison of Triple Antiplatelet Therapy with Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation in Diabetic Patients).
Lee SW; Park SW; Kim YH; Yun SC; Park DW; Lee CW; Hong MK; Kim HS; Ko JK; Park JH; Lee JH; Choi SW; Seong IW; Cho YH; Lee NH; Kim JH; Chun KJ; Park SJ
J Am Coll Cardiol; 2008 Mar; 51(12):1181-7. PubMed ID: 18355656
[TBL] [Abstract][Full Text] [Related]
19. Randomized comparison of cilostazol vs clopidogrel after drug-eluting stenting in diabetic patients--clilostazol for diabetic patients in drug-eluting stent (CIDES) trial.
Ahn Y; Jeong MH; Jeong JW; Kim KH; Ahn TH; Kang WC; Park CG; Kim JH; Chae IH; Nam CW; Hur SH; Bae JH; Kim KY; Oh SK
Circ J; 2008 Jan; 72(1):35-9. PubMed ID: 18159096
[TBL] [Abstract][Full Text] [Related]
20. Randomized comparison of cilostazol vs ticlopidine for antiplatelet therapy after coronary stenting.
Takeyasu N; Watanabe S; Noguchi Y; Ishikawa K; Fumikura Y; Yamaguchi I
Circ J; 2005 Jul; 69(7):780-5. PubMed ID: 15988102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
